Posted by Michael Wonder on 13 Jun 2024
Adtralza (tralokinumab) pre-filled pen now available in Canada
12 June 2024 - The single-use 2 mL pre-filled pen is an additional injection choice for administering Adtralza for the treatment of moderate to severe atopic dermatitis.
Leo Pharma today announced the availability of the Adtralza (tralokinumab 300 mg/2 mL) pre-filled pen in Canada.
